IL-6-independent association of elevated serum neopterin levels with prevalent frailty in community-dwelling older adults.

BACKGROUND neopterin is a monocyte/macrophage-derived immune activation marker and its levels increase with age. Frailty is an important clinical syndrome of old age. Previous studies have shown significant association between elevated interleukin-6 (IL-6) levels and frailty. The objective of this study was to evaluate IL-6-independent association of serum neopterin levels with prevalent frailty. METHODS this is a cross-sectional study in community-dwelling older adults recruited from residential and retirement communities in Baltimore, MD, USA. Frailty was determined using validated screening criteria. Serum neopterin and IL-6 levels were measured using standard enzyme-linked immunosorbent assay. Pearson correlation and multivariate linear regression analysis was performed to assess the relationship between log(neopterin) and log(IL-6). Odds ratios (ORs) for frailty were calculated using log(neopterin) and log(IL-6) as continuous measures and across tertiles of neopterin and IL-6 levels, adjusting for age, race, sex, education and body mass index. RESULTS one hundred and thirty-three individuals with a mean age of 84 years (range 72-97) completed the study. Neopterin levels were significantly higher in frail older adults than those in non-frail controls [median: 8.94 versus 8.35 nM, respectively, P < 0.001 t-test on log(neopterin)]. Log(neopterin) was significantly associated with prevalent frailty, adjusting for log(IL-6). Participants in the top tertile of neopterin had OR of 3.80 [95% confidence interval (CI) = 1.36-10.6, P < 0.01] for frailty. As expected, participants in the top tertile of IL-6 had OR of 3.29 (95% CI = 1.21-7.86, P < 0.05) for frailty. Log(neopterin) correlated with log(IL-6) (correlation coefficient = 0.19, P < 0.05). Moreover, OR for participants in the top neopterin tertile remained significant after adjusting for IL-6 (OR = 3.97, 95% CI = 1.15-13.72, P < 0.05). CONCLUSION elevated neopterin levels had IL-6-independent association with prevalent frailty, suggesting potential monocyte/macrophage-mediated immune activation in the frail elderly.

[1]  N. Punjabi,et al.  Serum levels of the immune activation marker neopterin change with age and gender and are modified by race, BMI, and percentage of body fat. , 2010, The journals of gerontology. Series A, Biological sciences and medical sciences.

[2]  L. Ferrucci,et al.  Nonlinear multisystem physiological dysregulation associated with frailty in older women: implications for etiology and treatment. , 2009, The journals of gerontology. Series A, Biological sciences and medical sciences.

[3]  L. Fried,et al.  Associations of neutrophil and monocyte counts with frailty in community-dwelling disabled older women: Results from the Women’s Health and Aging Studies I , 2009, Experimental Gerontology.

[4]  S. Leng,et al.  Upregulated monocytic expression of CXC chemokine ligand 10 (CXCL-10) and its relationship with serum interleukin-6 levels in the syndrome of frailty. , 2009, Cytokine.

[5]  L. Ferrucci,et al.  Upregulated ex vivo expression of stress-responsive inflammatory pathway genes by LPS-challenged CD14+ monocytes in frail older adults , 2009, Mechanisms of Ageing and Development.

[6]  N. Punjabi,et al.  Elevated levels of neopterin in sleep-disordered breathing. , 2007, Chest.

[7]  L. Fried,et al.  Inflammation and Frailty in Older Women , 2007, Journal of the American Geriatrics Society.

[8]  J. Löwer,et al.  Neopterin levels during the early phase of human immunodeficiency virus, hepatitis C virus, or hepatitis B virus infection , 2006, Transfusion.

[9]  L. Ferrucci,et al.  Interleukin-6 in aging and chronic disease: a magnificent pathway. , 2006, The journals of gerontology. Series A, Biological sciences and medical sciences.

[10]  L. Fried,et al.  Chronic Cytomegalovirus Infection and Inflammation Are Associated with Prevalent Frailty in Community‐Dwelling Older Women , 2005, Journal of the American Geriatrics Society.

[11]  H. Saito,et al.  Impaired systemic cell-mediated immunity and increased susceptibility to acute respiratory tract infections in patients with COPD. , 2005, Respiratory medicine.

[12]  J. Fahey,et al.  Serum neopterin, an immune activation marker, independently predicts disease progression in advanced HIV-1 infection. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  D. Fuchs,et al.  Increasing production of homocysteine and neopterin and degradation of tryptophan with older age. , 2004, Clinical biochemistry.

[14]  J. Kaski,et al.  Markers of inflammation and multiple complex stenoses (pancoronary plaque vulnerability) in patients with non-ST segment elevation acute coronary syndromes , 2004, Heart.

[15]  S. Leng,et al.  Serum levels of insulin-like growth factor-I (IGF-I) and dehydroepiandrosterone sulfate (DHEA-S), and their relationships with serum interleukin-6, in the geriatric syndrome of frailty , 2004, Aging clinical and experimental research.

[16]  L. Ferrucci,et al.  Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. , 2004, The journals of gerontology. Series A, Biological sciences and medical sciences.

[17]  D. Fuchs,et al.  Association of increased neopterin production with decreased humoral immunity in the elderly , 2003, Experimental Gerontology.

[18]  D. Fuchs,et al.  Acute cytomegalovirus infections in blood donors are indicated by increased serum neopterin concentrations , 2002, Medical Microbiology and Immunology.

[19]  Kathleen Koenig,et al.  Serum Interleukin‐6 and Hemoglobin as Physiological Correlates in the Geriatric Syndrome of Frailty: A Pilot Study , 2002, Journal of the American Geriatrics Society.

[20]  D. Fuchs,et al.  Neopterin as a marker for immune system activation. , 2002, Current drug metabolism.

[21]  L. Lipsitz.  Dynamics of stability: the physiologic basis of functional health and frailty. , 2002, The journals of gerontology. Series A, Biological sciences and medical sciences.

[22]  B. Melichar,et al.  Biochemical profile and survival in nonagenarians. , 2001, Clinical biochemistry.

[23]  L. Fried,et al.  Frailty in older adults: evidence for a phenotype. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.

[24]  J. Fahey,et al.  Distinct categories of immunologic changes in frail elderly , 2000, Mechanisms of Ageing and Development.

[25]  D. Fuchs,et al.  Serum soluble markers of immune activation and disease activity in systemic lupus erythematosus , 1995, Lupus.

[26]  E. Werner,et al.  Approach to define “normal aging” in man. Immune function, serum lipids, lipoproteins and neopterin levels , 1988, Mechanisms of Ageing and Development.

[27]  R. Souchon,et al.  Serum Neopterin Levels in Lung and Breast Cancer Patients Undergoing Radiotherapy And/Or Chemotherapy , 1988, The International journal of biological markers.

[28]  D. Fuchs,et al.  [Neopterin: new immunological marker of autoimmune rheumatic disease]. , 2000, Klinicheskaia meditsina.

[29]  T. Takahashi.  [Erythematosus]. , 1971, Nihon rinsho. Japanese journal of clinical medicine.